Fig. 1
From: sRAGE and early signs of cardiac target organ damage in mild hypertensives
sRAGE in normotensive subjects and in hypertensive patients with or without target organ damage. Lower sRAGE levels were observed in hypertensive patients with target organ damage (Hyp-TOD) when compared with hypertensives without target organ damage (Hyp-withoutTOD) (p = 0.038) and with normotensive subjects (p = 0.040). Columns show plasma levels of sRAGE in: hypertensive patients with cardiac target organ damage (Hyp-TOD), hypertensive patients without cardiac target organ damage (Hyp-without TOD), normotensive subjects. Plasma sRAGE concentration is expressed in natural logarithm. Bars show standard deviations of the three values. *Means statistical significance of the sRAGE levels between Hyp-TOD and Hyp-without TOD. °Means statistical significance of the sRAGE levels between Hyp-without TOD and Normotensives. #Means statistical significance of the sRAGE levels between Hyp-TOD and normotensives